Abstract
Recombinant human interleukin-1 receptor antagonist was expressed in E. coli as an insoluble inclusion body. The inclusion body was dissolved in the 8 M urea and then the solution was diluted untill the concentration of urea became 2 M. By ion exchange chromatography the protein in the solution of 2 M urea was refolded and purified. At last the purity of product is more than 95% and its bioactivity is more than 1 x 10(5) IU/mg while it has little endotoxin. Western-Blotting also indicates that recombinant protein can react with antibodies against anti-hIL-1ra.
| Original language | English |
|---|---|
| Pages (from-to) | 1128-1132 |
| Number of pages | 5 |
| Journal | Shengwu Yixue Gongchengxue Zazhi/Journal of Biomedical Engineering |
| Volume | 24 |
| Issue number | 5 |
| State | Published - Oct 2007 |
Fingerprint
Dive into the research topics of '[Using process of refolding the protein to obtain recombinant human interleukin-1 receptor antagonist].'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver